Département de Chirurgie, Institut Universitaire de la Face et du Cou, Centre Antoine Lacassagne, 33 avenue de Valombrose, 06189 Nice, France.
Eur Arch Otorhinolaryngol. 2010 May;267(5):751-8. doi: 10.1007/s00405-009-1138-x. Epub 2009 Nov 5.
The aims of this retrospective study were to evaluate prosthetic voice restoration by tracheoesophageal puncture (TEP) in laryngectomized patients and to identify clinical factors correlated with functional outcomes. Between 2000 and 2008, 103 patients who underwent total laryngectomy or pharyngolaryngectomy (TPL) were included in our study. Functional outcomes were recorded 6 months postoperatively, and results were scored from 0 to 2 for oral diet and speech intelligibility. Lifetime of voice prosthesis and early and late complications were recorded. The impact of several clinical factors on functional outcomes, prosthetic valve lifetime and complications was assessed in univariate analysis. A total of 87 patients (84%) underwent TEP and speech valve placement (79 primary and 8 secondary punctures). Hypopharyngeal tumors (P = 0.005), circular TPL (P = 0.003) and use of a pectoralis major myocutaneous flap (P = 0.0003) were significantly associated with secondary TEP. Successful voice rehabilitation was obtained by 77 of 82 evaluable patients (82%). A high level of comorbidity (ASA score > or = 3; P = 0.003) was correlated to speech rehabilitation failure. The median device lifetimes were 7.6 and 3.7 months for Provox I and II speech valves, respectively. Minor leakage around the valve occurred in 26% of the patients. Late complications occurred in 14 patients (16%) including: severe enlargement of the fistula (n = 3), prosthesis displacement (n = 7) and granulation tissue-formation (n = 4). In conclusion the use of voice prosthesis showed a high success rate of vocal rehabilitation with an acceptable complication rate.
本回顾性研究旨在评估经气管食管穿刺(TEP)进行喉切除术患者的假体嗓音恢复情况,并确定与功能结果相关的临床因素。2000 年至 2008 年,我们研究纳入了 103 例接受全喉切除术或咽喉切除术(TPL)的患者。术后 6 个月记录功能结果,并对口腔饮食和言语可懂度进行 0-2 分评分。记录了假体使用寿命和早期及晚期并发症。在单因素分析中评估了多种临床因素对功能结果、假体阀使用寿命和并发症的影响。总共 87 例患者(84%)进行了 TEP 和语音阀植入(79 例为原发性,8 例为继发性穿刺)。下咽肿瘤(P = 0.005)、圆形 TPL(P = 0.003)和胸大肌肌皮瓣的使用(P = 0.0003)与继发性 TEP 显著相关。82 例可评估患者中有 77 例(82%)获得了成功的嗓音康复。高合并症(ASA 评分≥3;P = 0.003)与言语康复失败相关。Provox I 和 II 语音阀的中位装置使用寿命分别为 7.6 个月和 3.7 个月。26%的患者出现阀门周围轻微泄漏。14 例患者(16%)发生晚期并发症,包括:瘘管严重增大(n = 3)、假体移位(n = 7)和肉芽组织形成(n = 4)。总之,使用语音假体可实现高成功率的嗓音康复,并发症发生率可接受。